US Oncology Research is a national leader in community-based cancer research, bringing patients the latest treatment options close to home through deep clinical expertise and high-quality solutions that help practices efficiently address the complexities involved in executing clinical trials in the community.
Investigators affiliated with US Oncology Research span every cancer type and stage and are dedicated to advancing cancer care. Together, we have contributed to some of the most important developments in cancer treatment, including the approval of 100 FDA-approved cancer therapies.
Since 1999, more than 80,000 patients have participated in approximately 1,600 clinical trials through practices associated with US Oncology Research.